Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of vinorelbine plus paclitaxel in treating patients with metastatic prostate cancer that is refractory to hormone therapy.

Timeline

Start

1999-01

Primary completion

2008-05

Completion

2017-02-22

Outcome

Outcome not reported

Stopped (Enrollment): “No recruitment”

Drugs

Indications